Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
COVID-19 (SARS-CoV-2) disease severity and stages varies from asymptomatic, mild flu-like symptoms, moderate, severe, critical, and chronic disease. COVID-19 disease progression include lymphopenia, elevated proinflammatory cytokines and chemokines, accumulation of macrophages and neutrophils in lun...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
Frontiers Media
2021
|
| Online Access: | https://hdl.handle.net/1721.1/130232 |